Intracranial Epidural Metastases of Adrenal Pheochromocytoma: A Rare Entity.

[1]  S. Challinor,et al.  Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma , 2017, Annals of Surgical Oncology.

[2]  W. Young,et al.  Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years , 2017, The Journal of clinical endocrinology and metabolism.

[3]  T. Bunchman,et al.  Review of Pediatric Pheochromocytoma and Paraganglioma , 2017, Front. Pediatr..

[4]  Y. Martin,et al.  Perioperative Management of Pheochromocytoma. , 2002, Journal of cardiothoracic and vascular anesthesia.

[5]  W. Young,et al.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[6]  C. Eng,et al.  Long-term prognosis of patients with pediatric pheochromocytoma. , 2013, Endocrine-related cancer.

[7]  E. Baudin,et al.  Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma , 2013, Current Oncology Reports.

[8]  S. Roman,et al.  Malignant pheochromocytoma and paraganglioma: A population level analysis of long‐term survival over two decades , 2013, Journal of surgical oncology.

[9]  Lei Feng,et al.  Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. , 2011, The Journal of clinical endocrinology and metabolism.

[10]  Karel Pacak,et al.  Phaeochromocytoma , 2005, The Lancet.

[11]  M. Giordano,et al.  Primary meningeal pheochromocytoma: case report , 2005, Journal of Neuro-Oncology.

[12]  David I. Smith,et al.  Malignant pheochromocytoma: current status and initiatives for future progress. , 2004, Endocrine-related cancer.

[13]  P. Rustin,et al.  Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. , 2003, Cancer research.

[14]  S. Argov,et al.  Malignant pheochromocytoma simulating meningioma: coexistence of recurrent meningioma and metastatic pheochromocytoma in the base of the skull. , 2002, The Israel Medical Association journal : IMAJ.

[15]  S. Gentile,et al.  Brain metastasis from pheochromocytoma in a patient with multiple endocrine neoplasia type 2A. , 2001, Panminerva medica.

[16]  E S Husebye,et al.  Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.

[17]  N. Abumrad,et al.  Clinical experience over 48 years with pheochromocytoma. , 1999, Annals of surgery.

[18]  T. Tsuji,et al.  Malignant pheochromocytoma with hepatic metastasis diagnosed 20 years after resection of the primary adrenal lesion. , 1993, Internal medicine.

[19]  C. Badet,et al.  Malignant pheochromocytoma: A series of 14 cases observed between 1966 and 1990 , 1992, Journal of endocrinological investigation.

[20]  R. Zappulla,et al.  Pheochromocytoma presenting as a skull metastasis with massive extracranial and intracranial extension. , 1990, Neurosurgery.

[21]  D. Aldovini,et al.  Cerebral metastases in pheochromocytoma. , 1979, Pathologica.

[22]  M. Melicow.  One hundred cases of pheochromocytoma (107 tumors) at the columbia‐presbyterian medical center, 1926‐1976. A clinicopathological analysis , 1977, Cancer.

[23]  Grayzel Dm,et al.  Pneochromocytoma of the adrenal medulla; a clinicopathological study of five cases. , 1948 .

[24]  E. W. Edwards,et al.  Pheochromocytoma of the adrenal medulla; its role in the pathogenesis of a malignant hypertension. , 1946, The Journal of clinical endocrinology and metabolism.